221 results on '"Harrison C"'
Search Results
2. Single-cell analysis identifies CRLF2 rearrangements as both early and late events in Down syndrome and non-Down syndrome acute lymphoblastic leukaemia
3. Clinical relevance of failed and missing cytogenetic analysis in acute myeloid leukaemia
4. Which patients with myelofibrosis should receive ruxolitinib therapy? ELN-SIE evidence-based recommendations
5. Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
6. A genome-wide association study identifies risk loci for childhood acute lymphoblastic leukemia at 10q26.13 and 12q23.1
7. Equivalence of BCSH and WHO diagnostic criteria for ET
8. Indication and management of allogeneic stem cell transplantation in primary myelofibrosis: a consensus process by an EBMT/ELN international working group
9. Refinement of IKZF1 status in pediatric Philadelphia-positive acute lymphoblastic leukemia
10. The pre-B-cell receptor checkpoint in acute lymphoblastic leukaemia
11. Clinical end points for drug treatment trials in BCR-ABL1-negative classic myeloproliferative neoplasms: consensus statements from European LeukemiaNET (ELN) and Internation Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT)
12. High hyperdiploidy among adolescents and adults with acute lymphoblastic leukaemia (ALL): cytogenetic features, clinical characteristics and outcome
13. An international study of intrachromosomal amplification of chromosome 21 (iAMP21): cytogenetic characterization and outcome
14. No chromosome arm unturned: in memory of Roland Berger 1934–2012
15. Hyperdiploidy with 49–65 chromosomes represents a heterogeneous cytogenetic subgroup of acute myeloid leukemia with differential outcome
16. Ruxolitinib and survival improvement in patients with myelofibrosis
17. Long-term follow-up of ETV6–RUNX1 ALL reveals that NCI risk, rather than secondary genetic abnormalities, is the key risk factor
18. Distinct patterns of gained chromosomes in high hyperdiploid acute lymphoblastic leukemia with t(1;19)(q23;p13), t(9;22)(q34;q22) or MLL rearrangements
19. Outcome in children with Down's syndrome and acute lymphoblastic leukemia: role of IKZF1 deletions and CRLF2 aberrations
20. Cytogenetics and outcome of infants with acute lymphoblastic leukemia and absence of MLL rearrangements
21. Haploinsufficiency of the MLL and TOB2 genes in lymphoid malignancy
22. Activating mutation in the TSLPR gene in B-cell precursor lymphoblastic leukemia
23. Long-term follow-up of the United Kingdom medical research council protocols for childhood acute lymphoblastic leukaemia, 1980–2001
24. Strong association of the HLA-DP6 supertype with childhood leukaemia is due to a single allele, DPB1*0601
25. A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin
26. Heterogeneous patterns of amplification of the NUP214-ABL1 fusion gene in T-cell acute lymphoblastic leukemia
27. Disruption of ETV6 in intron 2 results in upregulatory and insertional events in childhood acute lymphoblastic leukaemia
28. A unified definition of clinical resistance/intolerance to hydroxyurea in essential thrombocythemia: results of a consensus process by an international working group
29. Deletion of chromosome 13 detected by conventional cytogenetics is a critical prognostic factor in myeloma
30. The eighth international childhood acute lymphoblastic leukemia workshop (‘Ponte di Legno meeting’) report: Vienna, Austria, April 27–28, 2005
31. Erratum: Equivalence of BCSH and WHO diagnostic criteria for ET
32. Erratum: Long-term findings from COMFORT-II, a phase 3 study of ruxolitinib vs best available therapy for myelofibrosis
33. Treatment strategy and long-term results in paediatric patients treated in consecutive UK AML trials
34. Age has a profound effect on the incidence and significance of chromosome abnormalities in myeloma
35. Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia
36. No prognostic effect of additional chromosomal abnormalities in children with acute lymphoblastic leukemia and 11q23 abnormalities
37. Amplification of the ABL gene in T-cell acute lymphoblastic leukemia
38. Secondary cytogenetic aberrations in childhood Philadelphia chromosome positive acute lymphoblastic leukemia are nonrandom and may be associated with outcome
39. Loss of chromosomes is the primary event in near-haploid and low-hypodiploid acute lymphoblastic leukemia
40. Prenatal origin of hyperdiploid acute lymphoblastic leukemia in identical twins
41. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements
42. Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases
43. Establishing optimal quantitative-polymerase chain reaction assays for routine diagnosis and tracking of minimal residual disease in JAK2-V617F-associated myeloproliferative neoplasms: a joint European LeukemiaNet/MPN&MPNr-EuroNet (COST action BM0902) study
44. BTG1 deletions do not predict outcome in Down syndrome acute lymphoblastic leukemia
45. MLL amplification in acute leukaemia: a United Kingdom Cancer Cytogenetics Group (UKCCG) study
46. A new recurrent translocation t(11;14)(q24;q32) involving IGH@ and miR-125b-1 in B-cell progenitor acute lymphoblastic leukemia
47. A unique variant of ETV6/AML1 fusion in a child with acute lymphoblastic leukemia
48. Amplification of AML1 in acute lymphoblastic leukemia is associated with a poor outcome
49. Frequency of ETV6/AML1 fusion in adult acute lymphoblastic leukemia: Response to Cuneo et al
50. The role of the RAS pathway in iAMP21-ALL
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.